Editas Medicine, Inc. (EDIT) earnings date
Mar 3, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 42 days, typically, give or take 13 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Nov 9, 2026 | before open | 40 | 8-K |
| Q2 FY2026 | Wed, Aug 5, 2026 | after close | 36 | 8-K |
| Q1 FY2026 | Tue, May 5, 2026 | before open | 35 | 8-K |
| Q4 FY2025 | Mon, Mar 9, 2026 | before open | 68 | 8-K |
| Q3 FY2025 | Mon, Nov 10, 2025 | before open | 41 | 8-K |
| Q2 FY2025 | Tue, Aug 12, 2025 | after close | 43 | 8-K |
| Q1 FY2025 | Mon, May 12, 2025 | after close | 42 | 8-K |
| Q4 FY2024 | Wed, Mar 5, 2025 | after close | 64 | 8-K |
What they guided beta
| Q3 FY2026 | "The Company remains on track to begin patient dosing this year and report initial safety and tolerability data in the first quarter of 2027." exhibit |
| Q3 FY2026 | "The Company expects to complete enrollment in Part 1 of the Strive study, with topline safety and efficacy results from Part 1 available in the second half of 2027." exhibit |
| Q3 FY2026 | "The Company expects that its existing cash, cash equivalents, and marketable securities will enable the Company to fund its operating expenses and capital expenditure requirements into the second half of 2028." exhibit |
| Q2 FY2026 | "We look forward to our continued progress and expect to provide a data update in the first quarter of 2027.”" exhibit |
| Q2 FY2026 | "The Company expects to report a data update in the first quarter of 2027." exhibit |
| Q2 FY2026 | "The Company expects that the existing cash and cash equivalents will enable the Company to fund its operating expenses and capital expenditure requirements into the second half of 2028." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/EDIT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/EDIT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/EDIT/"><img src="https://veritasdata.dev/embed/EDIT.svg" alt="EDIT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/EDIT/)
Script
<script async src="https://veritasdata.dev/embed/EDIT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/EDIT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.